Procept BioRobotics Corporation Insider Trading

PRCT

⊜ Compare

Last 12 months

Insiders bought $11M and sold 624K on the open market.

36% of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

+$10.4M

2 buys · 12 sales

Under a 10b5-1 plan

36%

of the value sold

Insiders who bought / sold

2 / 3

executives and directors

Last open-market buy

Aug 2026

Aug 7, 2026

Get an email when PRCT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 9	Kevin Waters EVP, CFO	SoldNo plan	373	$20.95	8K	0.2%	Form 4
Sep 9	Alaleh Nouri EVP, CLO, Corp. Sec.	SoldNo plan	297	$20.95	6K	0.2%	Form 4
Sep 9	Barry L Templin EVP, Chief Technology Officer	SoldNo plan	373	$20.95	8K	0.4%	Form 4
Aug 7	Larry L Wood President, CEO	Bought	23,900	$20.85	498K	7.6%	Form 4
Jun 8	Alaleh Nouri EVP, CLO, Corp. Sec.	SoldNo plan	285	$28.48	8K	0.3%	Form 4
Jun 8	Kevin Waters EVP, CFO	SoldNo plan	357	$28.48	10K	0.2%	Form 4
Jun 8	Barry L Templin EVP, Chief Technology Officer	SoldNo plan	358	$28.48	10K	0.5%	Form 4
Mar 19	Alaleh Nouri EVP, CLO, Corp. Sec.	Sold10b5-1 plan 2 parts	5,363	$25.96 average	139K	4.8%	Form 4
Mar 17	Alaleh Nouri EVP, CLO, Corp. Sec.	SoldNo plan	304	$28.15	9K	0.3%	Form 4
Mar 17	Kevin Waters EVP, CFO	SoldNo plan	706	$28.15	20K	0.5%	Form 4
Mar 10	Alaleh Nouri EVP, CLO, Corp. Sec.	Sold10b5-1 plan 2 parts	3,243	$25.65 average	83K	2.8%	Form 4
Mar 5 – 9	Antal Rohit Desai Director	Bought 7 parts	426,262	$24.59 average	$10.5M	861%	Form 4
Mar 6	Alaleh Nouri EVP, CLO, Corp. Sec.	SoldNo plan	6,892	$23.70	163K	5.7%	Form 4
Mar 6	Kevin Waters EVP, CFO	SoldNo plan	6,721	$23.70	159K	4.2%	Form 4
Aug 13, 2025	Frederic H Moll Director	Bought	20,000	$39.26	785K	2.4%	Form 4
Jun 10, 2025 – Jun 12, 2025	Antal Rohit Desai Director	Sold10b5-1 plan 8 parts	75,000	$62.93 average	$4.72M	64%	Form 4
Jun 6, 2025	Hisham Shiblaq EVP, Chief Comm. Officer	SoldNo plan 3 parts	20,000	$64.13 average	$1.28M	24%	Form 4
Jun 3, 2025 – Jun 5, 2025	Antal Rohit Desai Director	Sold10b5-1 plan 13 parts	75,000	$62.16 average	$4.66M	46%	Form 4
Mar 18, 2025	Reza Zadno President, CEO	SoldNo plan	5,475	$57.06	312K	3.1%	Form 4
Mar 18, 2025	Kevin Waters EVP, CFO	SoldNo plan	733	$57.06	42K	0.7%	Form 4
Mar 18, 2025	Hisham Shiblaq EVP, Chief Comm. Officer	SoldNo plan	247	$57.06	14K	0.4%	Form 4
Mar 18, 2025	Alaleh Nouri EVP, CLO, Corp. Sec.	SoldNo plan	316	$57.06	18K	0.5%	Form 4
Mar 6, 2025	Alaleh Nouri EVP, CLO, Corp. Sec.	SoldNo plan	3,641	$61.31	223K	5.6%	Form 4
Mar 6, 2025	Hisham Shiblaq EVP, Chief Comm. Officer	SoldNo plan	3,588	$61.31	220K	5.4%	Form 4
Mar 6, 2025	Kevin Waters EVP, CFO	SoldNo plan	3,662	$61.31	225K	3.3%	Form 4
Mar 6, 2025	Reza Zadno President, CEO	SoldNo plan	15,916	$61.31	976K	8.2%	Form 4
Dec 4, 2024	Reza Zadno President, CEO	Sold10b5-1 plan 4 parts	26,423	$97.22 average	$2.57M	15%	Form 4
Dec 4, 2024	Alaleh Nouri EVP, CLO, Corp. Sec.	Sold10b5-1 plan 3 parts	28,092	$97.13 average	$2.73M	35%	Form 4
Nov 27, 2024	Reza Zadno President, CEO	Sold10b5-1 plan 4 parts	26,420	$97.83 average	$2.58M	13%	Form 4
Nov 20, 2024	Reza Zadno President, CEO	Sold10b5-1 plan 3 parts	26,420	$92.57 average	$2.45M	11%	Form 4
Nov 13, 2024	Reza Zadno President, CEO	Sold10b5-1 plan 4 parts	26,420	$94.08 average	$2.49M	10%	Form 4
Nov 6, 2024 – Nov 7, 2024	Antal Rohit Desai Director	Sold10b5-1 plan 8 parts	67,000	$96.20 average	$6.45M	28%	Form 4

Sep 9No plan
Kevin Waters
EVP, CFO · sold 373 at $20.95
8K
0.2% of stake
Sep 9No plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 297 at $20.95
6K
0.2% of stake
Sep 9No plan
Barry L Templin
EVP, Chief Technology Officer · sold 373 at $20.95
8K
0.4% of stake
Aug 7
Larry L Wood
President, CEO · bought 23,900 at $20.85
498K
7.6% of stake
Jun 8No plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 285 at $28.48
8K
0.3% of stake
Jun 8No plan
Kevin Waters
EVP, CFO · sold 357 at $28.48
10K
0.2% of stake
Jun 8No plan
Barry L Templin
EVP, Chief Technology Officer · sold 358 at $28.48
10K
0.5% of stake
Mar 1910b5-1 plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 5,363 at avg $25.96
139K
4.8% of stake
Mar 17No plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 304 at $28.15
9K
0.3% of stake
Mar 17No plan
Kevin Waters
EVP, CFO · sold 706 at $28.15
20K
0.5% of stake
Mar 1010b5-1 plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 3,243 at avg $25.65
83K
2.8% of stake
Mar 5 – 9
Antal Rohit Desai
Director · bought 426,262 at avg $24.59
$10.5M
861% of stake
Mar 6No plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 6,892 at $23.70
163K
5.7% of stake
Mar 6No plan
Kevin Waters
EVP, CFO · sold 6,721 at $23.70
159K
4.2% of stake
Aug 13, 2025
Frederic H Moll
Director · bought 20,000 at $39.26
785K
2.4% of stake
Jun 10, 2025 – Jun 12, 202510b5-1 plan
Antal Rohit Desai
Director · sold 75,000 at avg $62.93
$4.72M
64% of stake
Jun 6, 2025No plan
Hisham Shiblaq
EVP, Chief Comm. Officer · sold 20,000 at avg $64.13
$1.28M
24% of stake
Jun 3, 2025 – Jun 5, 202510b5-1 plan
Antal Rohit Desai
Director · sold 75,000 at avg $62.16
$4.66M
46% of stake
Mar 18, 2025No plan
Reza Zadno
President, CEO · sold 5,475 at $57.06
312K
3.1% of stake
Mar 18, 2025No plan
Kevin Waters
EVP, CFO · sold 733 at $57.06
42K
0.7% of stake
Mar 18, 2025No plan
Hisham Shiblaq
EVP, Chief Comm. Officer · sold 247 at $57.06
14K
0.4% of stake
Mar 18, 2025No plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 316 at $57.06
18K
0.5% of stake
Mar 6, 2025No plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 3,641 at $61.31
223K
5.6% of stake
Mar 6, 2025No plan
Hisham Shiblaq
EVP, Chief Comm. Officer · sold 3,588 at $61.31
220K
5.4% of stake
Mar 6, 2025No plan
Kevin Waters
EVP, CFO · sold 3,662 at $61.31
225K
3.3% of stake
Mar 6, 2025No plan
Reza Zadno
President, CEO · sold 15,916 at $61.31
976K
8.2% of stake
Dec 4, 202410b5-1 plan
Reza Zadno
President, CEO · sold 26,423 at avg $97.22
$2.57M
15% of stake
Dec 4, 202410b5-1 plan
Alaleh Nouri
EVP, CLO, Corp. Sec. · sold 28,092 at avg $97.13
$2.73M
35% of stake
Nov 27, 202410b5-1 plan
Reza Zadno
President, CEO · sold 26,420 at avg $97.83
$2.58M
13% of stake
Nov 20, 202410b5-1 plan
Reza Zadno
President, CEO · sold 26,420 at avg $92.57
$2.45M
11% of stake
Nov 13, 202410b5-1 plan
Reza Zadno
President, CEO · sold 26,420 at avg $94.08
$2.49M
10% of stake
Nov 6, 2024 – Nov 7, 202410b5-1 plan
Antal Rohit Desai
Director · sold 67,000 at avg $96.20
$6.45M
28% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PRCT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with PRCT

CompareIntrinsic value

TCMDTactile Systems Technology Inc.

$27.20+9.75%73

ANGOAngiodynamics Inc.

$12.27+4.60%40

MDXGMiMedx Group, Inc.

$3.20-1.54%18

SKINSkinHealth Systems Inc.

$11.05+6.76%42

LMATLemaitre Vascular Inc.

$87.89+9.04%72

ARAYAccuray Incorporated

$0.15+7.14%0

KIDSOrthoPediatrics Corp.

$33.51+6.69%45

CERSCerus Corporation

$2.42+3.21%32

Held by ETFs

PRCT is in 34 US ETFs. The largest of them, with PRCT's weight in each:

Spot a number that looks wrong? Check it in PRCT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PRCT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.